Q9992 HCPCS code: Injection, buprenorphine extended-release (sublocade), greater than 100 mg
Q9992 is the HCPCS Level II code for injection, buprenorphine extended-release (sublocade), greater than 100 mg. In 2024 Medicare paid an average of $716.11 per service for Q9992 across 336 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume rose 63% from 2022 to 2024 (206 to 336 services). In 2024, about 107 clinicians billed Medicare for Q9992 for 107 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2018-07-01 |
| Last action effective | 2018-07-01 |
Who bills Q9992 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 107 |
| Medicare beneficiaries | 107 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for Q9992, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 206 | 82 | $1,311.94 | $1,040.56 |
| 2023 | 253 | 90 | $1,289.54 | $1,021.33 |
| 2024 | 336 | 107 | $903.30 | $716.11 |
States with the most Q9992 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Massachusetts | 48 | $712.56 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Code Descriptor / CPT Instruction |
| practitioner claims | 1 | Code Descriptor / CPT Instruction |
What changed for Q9992
- 2018-07-01: Q9992 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q9992?
Q9992 is the HCPCS Level II code for injection, buprenorphine extended-release (sublocade), greater than 100 mg. Short descriptor: "Buprenorphine xr over 100 mg".
How much does Medicare pay for Q9992?
In 2024, the average Medicare payment was $716.11 per service (average allowed $903.30).
Does Medicare cover Q9992?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of Q9992 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related Q99 codes
- Q9950 — Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954 — Oral magnetic resonance contrast agent, per 100 ml
- Q9955 — Injection, perflexane lipid microspheres, per ml
- Q9956 — Injection, octafluoropropane microspheres, per ml
- Q9957 — Injection, perflutren lipid microspheres, per ml
- Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962 — High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q9992
- Watch Q9992 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q9992
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.